Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck

Strahlentherapie und Onkologie

Volumn 185, Issue 12, 2009, Pages 775-781

  Balermpas, Panagiotis ^a   Hambek, Markus ^a   Seitz, Oliver ^a   Rödel, Claus ^a   Weiss, Christian ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Antibody; Cetuximab; Head and neck cancer; Radiotherapy; Reirradiation

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; OPIATE DERIVATIVE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ACNE; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; DYSPHAGIA; EDEMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FIBROSIS; HEAD AND NECK CARCINOMA; HEARING; HUMAN; HYPERPIGMENTATION; INOPERABLE CANCER; MALE; MUCOSA INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PNEUMONIA; RADIATION DERMATITIS; RASH; RECURRENT CANCER; SALIVARY GLAND PAIN; SIALOADENITIS; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; TELANGIECTASIA; TREATMENT OUTCOME; TRISMUS; VOICE CHANGE; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG ADMINISTRATION; FOLLOW UP; MIDDLE AGED; MOUTH TUMOR; OROPHARYNX TUMOR; PATHOLOGY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RETREATMENT; TUMOR RECURRENCE;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETREATMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73449097157     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-2092-7     Document Type: Article

References (25)

1. J.A. Bonner P.M. Harari J. Giralt, et al. 2006 Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 567 578 10.1056/NEJMoa053422 1:CAS:528:DC%2BD28Xhtleksbs%3D 16467544 (Pubitemid 43209104)
2. D. Bottke K. Bathe T. Wiegel, et al. 2007 Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck Strahlenther Onkol 183 128 132 10.1007/s00066-007-1597-1 17340070 (Pubitemid 46364895)
3. B. Brockstein D.J. Haraf A.W. Rademaker, et al. 2004 Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience Ann Oncol 15 1179 1186 10.1093/annonc/mdh308 1:STN:280:DC%2BD2cznt1WmsQ%3D%3D 15277256 (Pubitemid 39199304)
4. B. Burtness M.A. Goldwasser W. Flood, et al. 2005 Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study J Clin Oncol 23 8646 8654 10.1200/JCO.2005.02.4646 16314626 (Pubitemid 46211507)
5. E.A. Eisenhauer P. Therasse J. Bogaerts, et al. 2009 New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 228 247 10.1016/j.ejca.2008.10.026 1:STN:280: DC%2BD1M%2Fgs12rug%3D%3D 19097774
6. E. Fokas U. Wacker M.W. Gross, et al. 2009 Hypofractionated stereotactic reirradiation of recurrent glioblastomas. A beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 185 235 240 10.1007/s00066-009-1753-x 19370426
7. M.K. Gibson Y. Li B. Murphy, et al. 2005 Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an Intergroup trial of the Eastern Cooperative Oncology Group J Clin Oncol 23 3562 3567 10.1200/JCO.2005.01.057 1:CAS:528:DC%2BD2MXlsVyhs78%3D 15908667 (Pubitemid 46243501)
8. G. Henke F. Paulsen J.P. Steinbach, et al. 2009 Hypofractionated reirradiation for recurrent malignant glioma Strahlenther Onkol 185 113 119 10.1007/s00066-009-1969-9 19240998
9. R.S. Herbst M. Arquette D.M. Shin, et al. 2005 Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck J Clin Oncol 23 5578 5587 10.1200/JCO.2005.07.120 1:CAS:528:DC%2BD2MXhtVersr%2FK 16009949 (Pubitemid 46300152)
10. B.A. Jereczek-Fossa A. Kowalczyk A. D'Onofrio, et al. 2008 Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients Strahlenther Onkol 184 36 40 10.1007/s00066-008-1783-9 18188521
11. 192Ir HDR brachytherapy Strahlenther Onkol 183 69 75 10.1007/s00066-007-1632-2 17294110 (Pubitemid 46255024)
12. J.A. Langendijk J. Bourhis 2007 Reirradiation in squamous cell head and neck cancer: recent developments and future directions Curr Opin Oncol 19 202 209 10.1097/CCO.0b013e3280f00ff8 17414637 (Pubitemid 46597478)
13. C.J. Langer J. Harris E.M. Horwitz, et al. 2007 Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group protocol 9911 J Clin Oncol 25 4800 4805 10.1200/JCO.2006.07.9194 1:CAS:528:DC%2BD2sXhtlCgsLbK 17947728 (Pubitemid 350086484)
14. S.R. Mabanta W.M. Mendenhall S.P. Stringer, et al. 1999 Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes Head Neck 21 591 594 10.1002/(SICI)1097-0347(199910)21:7<591::AID-HED1>3.0.CO;2-Y 1:STN:280:DyaK1MvhvV2qsw%3D%3D 10487944 (Pubitemid 29459862)
15. V. Milani M. Pazos R.D. Issels, et al. 2008 Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer Strahlenther Onkol 184 163 168 10.1007/s00066-008-1731-8 18330513
16. Milanovic D, Adebahr S, Henke M. Wiederbestrahlung mit Cetuximab bei Patienten mit rezidivierten Kopf-Hals Tumoren. Strahlenther Onkol 2009;185: Sondernr 1:95.
17. J.P. Pignon A. le Maitre E. Maillard, et al. 2009 Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 4 14 10.1016/j.radonc.2009.04.014 19446902
18. J.A. Ridge 1993 Squamous cancer of the head and neck: surgical treatment of local and regional recurrence Semin Oncol 20 419 429 1:STN:280: DyaK2c%2FisVShsg%3D%3D 7692603
19. J.K. Salama E.E. Vokes 2008 Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer Semin Oncol 35 251 261 10.1053/j.seminoncol.2008.03.010 1:CAS:528:DC%2BD1cXovFelt7g%3D 18544440 (Pubitemid 351787700)
20. S.A. Spencer J. Harris R.H. Wheeler, et al. 2001 RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck Int J Radiat Oncol Biol Phys 51 1299 1304 1:CAS:528:DC%2BD3MXos1Kmtrk%3D 11728690
21. P.M. Stell 1989 Survival times in end-stage head and neck cancer Eur J Surg Oncol 15 407 410 1:STN:280:DyaK3c%2Fgs1Sgsg%3D%3D 2792391
22. J.B. Vermorken R. Mesia F. Rivera, et al. 2008 Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 1116 1127 10.1056/NEJMoa0802656 1:CAS:528:DC%2BD1cXhtFWrsrnI 18784101
23. J.B. Vermorken E. Remenar C. van Herpen, et al. 2007 Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 1695 1704 10.1056/NEJMoa071028 1:CAS:528:DC%2BD2sXht1ansLvP 17960012 (Pubitemid 350005151)
24. S.J. Wong M. Machtay Y. Li 2006 Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 24 2653 2658 10.1200/JCO.2005.05.3850 16763279 (Pubitemid 46622086)
25. Zwicker F, Röder F, Münter M, et al. Kombinierte Radioimmuntherapie mit Cetuximab bei Re-Bestrahlungen von Karzinomrezidiven im Schädel-/Halsbereich. Strahlenther Onkol 2009;185:Sondernr 1:91.